TY - JOUR
T1 - Ante-natal counseling in phacomatoses
AU - Brabbing-Goldstein, Dana
AU - Ben-Shachar, Shay
N1 - Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Objectives: Phacomatoses are a group of neuro-oculo-cutaneous syndromes/ neurocutaneous disorders, involving structures arising from the embryonic ectoderm. Most of phacomatoses including the most common ones:, neurofibromatosis type I and type II (NF1, NF2) and tuberosclerosis complex (TSC), are autosomal dominant genetic disorders with full penetrance and variable expression. As no effective treatment exists, the only way to prevent the disease, is by prenatal genetic diagnosis (either chorionic villus sampling-CVS or amniocentesis-AC) and termination of pregnancy or performing preimplantation genetic testing (PGT). As the risk for an affected offspring is 50% in every pregnancy of an affected parent, prenatal, and preimplantation testing are of great importance. However, those procedures are associated with technical and ethical concerns. This chapter shortly reviews the common phacomatoses emphasizes their genetics and inheritance. We will review the common methods for prenatal and preimplantation diagnoses and discuss its use in common phacomatoses. Conclusion: Phacomatoses are common autosomal dominant genetic conditions with variable expression. Ante-natal genetic diagnosis is an appropriate approach for family planning in individuals affected by phacomatosis or parents of an affected child.
AB - Objectives: Phacomatoses are a group of neuro-oculo-cutaneous syndromes/ neurocutaneous disorders, involving structures arising from the embryonic ectoderm. Most of phacomatoses including the most common ones:, neurofibromatosis type I and type II (NF1, NF2) and tuberosclerosis complex (TSC), are autosomal dominant genetic disorders with full penetrance and variable expression. As no effective treatment exists, the only way to prevent the disease, is by prenatal genetic diagnosis (either chorionic villus sampling-CVS or amniocentesis-AC) and termination of pregnancy or performing preimplantation genetic testing (PGT). As the risk for an affected offspring is 50% in every pregnancy of an affected parent, prenatal, and preimplantation testing are of great importance. However, those procedures are associated with technical and ethical concerns. This chapter shortly reviews the common phacomatoses emphasizes their genetics and inheritance. We will review the common methods for prenatal and preimplantation diagnoses and discuss its use in common phacomatoses. Conclusion: Phacomatoses are common autosomal dominant genetic conditions with variable expression. Ante-natal genetic diagnosis is an appropriate approach for family planning in individuals affected by phacomatosis or parents of an affected child.
KW - Amniocentesis
KW - Chorionic villi sampling
KW - Germline gene editing
KW - Neurofibromatosis type 1
KW - Neurofibromatosis type 2
KW - Phacomatoses
KW - Preimplantation genetic testing
KW - Prenatal genetic counseling
KW - Prenatal genetic diagnosis
KW - Tuberosclerosis complex
UR - http://www.scopus.com/inward/record.url?scp=85087556747&partnerID=8YFLogxK
U2 - 10.1007/s00381-020-04776-3
DO - 10.1007/s00381-020-04776-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32623496
AN - SCOPUS:85087556747
SN - 0256-7040
VL - 36
SP - 2269
EP - 2277
JO - Child's Nervous System
JF - Child's Nervous System
IS - 10
ER -